Diopter Technologies

Somerville, MA · Medtech · Private

Drug-eluting contact lenses delivering antibiotics, steroids, and NSAIDs for post-surgical eye care

diopterlabs.com →
Grants
$943K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Sustained Triumvirate Delivery by Contact Lens for Post-Surgical Management$305,500
Federal grantDepartment of Health and Human Services · Phase I · Sustained Triumvirate Delivery by Contact Lens for Post-Surgical Management$305,500
Federal grantDepartment of Health and Human Services · Phase I · Sustained cysteamine delivery by nanobarrier contact lenses to replace 8xdaily drops with a daily disposable lens$332,179
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1736EKSO BIONICS HOLDINGS, INC.—$103M
1737BEAM - CA, LLC——
1738LUVOZO PBC——
1739Diopter Technologies——
1740DELCATH SYSTEMS, INC.—$72M
1741SCISIO GENETICS, INC.——
1742MIVI Neuroscience, Inc.—$67M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.